Litcius/Paper detail

High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases

Jake A. Ruddy, Caoilfhionn M Connolly, Brian J. Boyarsky, William A. Werbel, Lisa Christopher‐Stine, Jacqueline Garonzik‐Wang, Dorry L. Segev, Julie J. Paik

2021Annals of the Rheumatic Diseases138 citationsDOIOpen Access PDF

Topics & Concepts

MedicineVaccinationPandemicPer capitaAsymptomaticCoronavirus disease 2019 (COVID-19)Public healthCase fatality rateDemographyEmergency medicineEnvironmental healthImmunologyPopulationInternal medicineDiseaseInfectious disease (medical specialty)SociologyNursingSARS-CoV-2 and COVID-19 ResearchViral Infections and Immunology ResearchViral gastroenteritis research and epidemiology
High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases | Litcius